Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
News
Outbreaks
Vaccines
Zyesami (Aviptadil) Therapeutic
Zyesami (Aviptadil) Therapeutic
Fact checked by
Robert Carlson, MD
Aug 3
4 min read
First COVID Therapeutic To Block Replication of the SARS-CoV-2 in Human Lung Cells and Monocytes
NeuroRx Aviptadil (RLF-100) is a patented formulation of Vasoactive Intestinal Polypeptide
Coronavirus
COVID-19
SARS-CoV-2